SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-21-023575
Filing Date
2021-09-24
Accepted
2021-09-24 15:21:35
Documents
13

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 2256702
2 ex5-1.htm EX-5.1 14279
3 ex21-1.htm EX-21.1 6705
4 ex23-1.htm EX-23.1 5648
5 forms-1_001.jpg GRAPHIC 24391
6 forms-1_002.jpg GRAPHIC 22231
7 forms-1_003.jpg GRAPHIC 52118
8 forms-1_004.jpg GRAPHIC 21480
9 forms-1_005.jpg GRAPHIC 24474
10 finlogo_001.jpg GRAPHIC 4811
11 fin1_001.jpg GRAPHIC 4435
12 ex5-1_001.jpg GRAPHIC 3359
13 ex5-1_002.jpg GRAPHIC 3128
  Complete submission text file 0001493152-21-023575.txt   2506421
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-259771 | Film No.: 211277124
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences